Radiation Therapy
Stereotactic body radiation extends survival in hepatocellular carcinoma
Stereotactic body radiation therapy followed by sorafenib extended survival compared with sorafenib alone among patients with hepatocellular carcinoma, according to study results presented at ASCO Gastrointestinal Cancers Symposium.
Lobectomy alternatives show varying adverse event profiles in early-stage lung cancer
Although use of limited resection or stereotactic body radiation therapy for early-stage non-small cell lung cancer had comparable odds for at least one adverse event, the overall toxicity profiles differed, according to study results.
Concurrent ADT, radiation therapy improves outcomes in localized prostate cancer
Androgen deprivation therapy sequencing had a considerable effect on outcomes among men with prostate cancer who received prostate-only radiotherapy, according to study results published in Journal of Clinical Oncology.
Adding radiation to hormone therapy slows progression of oligometastatic prostate cancer
Adding localized radiation therapy to intermittent hormone therapy extended PFS among men with oligometastatic prostate cancer, data from the randomized phase 2 EXTEND trial showed.
Radiation therapy for asymptomatic bone metastases prolongs survival, prevents pain
Palliative radiation therapy for high-risk asymptomatic bone metastases significantly prolonged OS while reducing skeletal-related events compared with standard therapy, phase 2 trial results showed.
Hypofractionated radiation therapy ‘new standard of care’ for high-risk prostate cancer
Men with high-risk prostate cancer who received a shorter course of radiation therapy had similar survival and recurrence rates as those who received a longer, standard radiation therapy course, phase 3 trial results showed.
Hypofractionated whole-breast irradiation safe, effective for certain early breast cancers
A 3-week course of hypofractionated whole-breast radiation therapy appeared as safe and effective as a conventional treatment course among patients with early-stage breast cancer at high risk for recurrence.
Adding radiation therapy to sorafenib extends survival in advanced liver cancer
The addition of stereotactic body radiation therapy to sorafenib extended OS among patients with advanced hepatocellular carcinoma, results of the randomized phase 3 NRG Oncology/RTOG 1112 trial showed.
Recurrent mobile spine chondroma yielded high rate of complications
CHICAGO — Results presented at the North American Spine Society Annual Meeting showed patients with recurrent mobile spine chondromas had a high rate of complications with or without surgical management.
Oral health professionals promote ‘value of having a dentist on the cancer care team’
When planning their next steps after a cancer diagnosis, most patients don’t put a trip to the dentist at the top of their to-do list.